ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Victor A Ferraris
Suellen P. Ferraris
Frederick C. Lough
William R. Berry
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferraris, V. A.
Right arrow Articles by Berry, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferraris, V. A.
Right arrow Articles by Berry, W. R.

Ann Thorac Surg 1995;59:1036-1037
© 1995 The Society of Thoracic Surgeons


Articles

Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting

Victor A Ferraris, M.D., Ph.D., LTC, MC*, Suellen P. Ferraris, Ph.D., Frederick C. Lough, M.D., LTC, MC, William R. Berry, M.D., MAJ, MC

* Address reprint requests to Dr Victor A. Ferraris, Division of Cardiothoracic Surgery, Albany Medical College, Suite A330/A-61, 47 New Scotland Ave, Albany, NY 12208.
Updated in 1995 by Victor A. Feraris, MD, PhD, and Suellen P. Ferraris, PhD Division of Cardiothoracic Surgery, Albany Medical College, Albany, New York

Thirty-four patients were entered into a non-blinded, randomized study to test the effect of preoperative aspirin ingestion on postoperative blood loss and transfusion requirements after coronary artery bypass grafting. Sixteen patients in the aspirin-treated group had significantly increased chest-tube blood loss 12 hours after operation (1,513 ± 978 versus 916 ± 482 ml; p = 0.038). In addition, aspirin users had significantly increased requirements for postoperative packed red blood cells (4.4 ± 3.5 versus 1.8 ± 1.3 units; p = 0.014), platelets (1.3 ± 1.3 versus 0.2 ± 0.4 six-donor units, p = 0.0049), and fresh-frozen plasma (3.6 ± 5.0 versus 0.78 ± 1.6 units; p = 0.042) transfusions. The only patients requiring reoperation for bleeding were in the aspirin-treated group (2 patients). Six patients were not entered into the randomized part of the study because of excessively prolonged post-aspirin bleeding times (> 10 minutes). This finding suggests that a subset of patients are particularly sensitive to aspirin and have significantly prolonged bleeding times after aspirin ingestion. We conclude that aspirin ingestion increases postoperative blood loss and transfusion requirements, and we recommend discontinuation of aspirin therapy before cardiac procedures.




This article has been cited by other articles:


Home page
Eur J Cardiothorac SurgHome page
G. Suwalski, P. Suwalski, K. J. Filipiak, M. Postula, F. Majstrak, and G. Opolski
The effect of off-pump coronary artery bypass grafting on platelet activation in patients on aspirin therapy until surgery day
Eur J Cardiothorac Surg, August 1, 2008; 34(2): 365 - 369.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
G. Renda, R. Di Pillo, A. D'Alleva, A. Sciartilli, M. Zimarino, E. De Candia, R. Landolfi, G. Di Giammarco, A. Calafiore, and R. De Caterina
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery
Haematologica, March 1, 2007; 92(3): 366 - 373.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. M. Karski and J. T. Balatbat
Blood Conservation Strategies in Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2003; 7(2): 175 - 188.
[Abstract] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
K. Kottke-Marchant and S. Sapatnekar
Hemostatic Abnormalities in Cardiopulmonary Bypass: Pathophysiologic and Transfusion Considerations
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 187 - 206.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. C. Silvestry and P. K. Smith
Current status of cardiac surgery in the abciximab-treated patient
Ann. Thorac. Surg., August 1, 2000; 70(2): S12 - 19.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. L. Kaluza, J. Joseph, J. R. Lee, M. E. Raizner, and A. E. Raizner
Catastrophic outcomes of noncardiac surgery soon after coronary stenting
J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1288 - 1294.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
S. M. Lanzkron and W. R. Bell
State-of-the-Art Review : Management of Patients Who Require Invasive Procedures Immediately Following Thrombolytic Therapy
Clinical and Applied Thrombosis/Hemostasis, July 1, 1996; 2(3): 158 - 163.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.